Ribociclib

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest
 (RY-boh-SY-klib)

This page contains brief information about ribociclib and a collection of links to more information about the use of this drug, research results, and ongoing clinical trials.

US Brand Name(s)
Kisqali
FDA Approved
Yes

FDA Approval for Ribociclib

Use in Cancer

Ribociclib is approved to be used with an aromatase inhibitor to treat:

Ribociclib is also being studied in the treatment of other types of cancer.

More About Ribociclib

Definition from the NCI Drug Dictionary - Detailed scientific definition and other names for this drug.

Research Results and Related Resources

FDA Approves Ribociclib, Expands Palbociclib Approval for Metastatic Breast Cancer

Ribociclib Improves Progression-Free Survival for Some Women with Metastatic Breast Cancer

Clinical Trials Accepting Patients

Find Clinical Trials for Ribociclib - Check for trials from NCI's list of cancer clinical trials now accepting patients.

  • Posted: March 16, 2017
  • Updated: April 11, 2017